CAS: 1489389-18-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT245737 REF: AN-AG00ABR8CAS: 1489389-18-5 | 97+% | 90.00 €~583.00 € | Thu 02 May 24 |
 | CCT245737 REF: TM-T7080CAS: 1489389-18-5 | 99.69% | 39.00 €~541.00 € | Thu 09 May 24 |
 | CCT245737 REF: 3D-PJC38918CAS: 1489389-18-5 | Min. 95% | To inquire | Thu 13 Jun 24 |
CCT245737
CAS:1489389-18-5
Formula:
C16H16F3N7O
Purity:
97+%
Color and Shape:
Solid
Molecular weight:
379.3397
Ref: AN-AG00ABR8
| 5mg | 90.00 € | |
| 10mg | 124.00 € | |
| 25mg | 174.00 € | |
| 50mg | 275.00 € | |
| 100mg | 583.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
CCT245737
CAS:1489389-18-5
CCT245737 (SRA737) is an orally active and selective Chk1 inhibitor (IC50: 1.3 nM); CCT245737 shows …
Formula:
C16H16F3N7O
Purity:
99.69%
Color and Shape:
Solid
Molecular weight:
379.34
Ref: TM-T7080
| 1mg | 39.00 € | |
| 2mg | 51.00 € | |
| 5mg | 82.00 € | |
| 10mg | 118.00 € | |
| 25mg | 220.00 € | |
| 50mg | 363.00 € | |
| 100mg | 541.00 € | |
| 1ml*10 (DMSO) | 90.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
CCT245737
CAS:1489389-18-5
CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The …
Formula:
C16H16F3N7O
Purity:
Min. 95%
Molecular weight:
379.34 g/mol
Ref: 3D-PJC38918
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
